Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Alamartine, E.
Right arrow Articles by Berthoux, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alamartine, E.
Right arrow Articles by Berthoux, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 12, Issue 5 988-994, Copyright © 1997 by Oxford University Press

ORIGINAL ARTICLES

Lack of evidence for natural cytotoxicity deficiency against human ex vivo tumour cells in allograft recipients

E Alamartine, O Sabido, J Dumollard and F Berthoux
Groupe de Recherche sur les Glomerulonephrites et la Transplantation Renale, UPRES 773, Saint-Etienne Cedex, France; Centre Commun de Cytometrie en Flux, France; Laboratoire d'Anatomie Pathologie, Faculte de Medecine de Saint-Etienne, Saint-Etienne, France; Correspondence to E Alamartine, Service de Nephrologie, Dialyse, Transplantation Renale, Hopital Nord, 42055 Saint-Etienne Cedex 02, France

Background. Allograft recipients, who have a high risk of developing malignancies, are deficient in natural killer cells which mediate natural cytotoxicity against tumour cells. We evaluated the relevance of NK deficiency in transplant patients with regard to the natural lysis of human tumour cells. Methods. Target cells were ex vivo tumour cells, obtained from solid tumours from kidney transplant patients and non-immunocompromised patients. Peripheral blood was extracted from kidney recipients and from normal controls. Mononuclear cells were separated after anti-CD3 and anti-TCR immunostaining to obtain NK and T cell subsets. LAK cells were obtained by in vitro IL2-activation. For each tumour, natural cytotoxicity assays were performed to compare effector cells from a kidney recipient with those from a normal control. Twenty-seven solid tumours, either allogenic or syngenic, were analysed, mainly consisting of renal, colon, and skin carcinomas. Results. Natural cytotoxicity assays on K562 targets confirmed the expected NK deficiency in the kidney recipients. However, the NK and LAK cells from the kidney recipients did not kill a smaller number of tumour target cells than the controls, whatever the tumour type, under both the syngenic and allogenic conditions. Conclusions. We conclude that natural cytotoxicity against human tumour cells cannot be extrapolated from the cytotoxicity assays with established cell lines, and that natural lysis of ex vivo human tumour cells is not impaired in transplant patients. Keywords: natural killer cells; natural cytotoxicity; transplantation; tumour cells
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.